logo-loader

Lexagene Holdings Inc

Receive alerts
Market:
TSX-V
Market Cap:
$42.83 m
Price
0.50 CAD
Change
2.04%
52 weeks high
0.93
52 weeks low
0.45

In brief

LexaGene is a biotechnology company developing a fully automated pathogen detection platform for use at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene’s technology aims to transform the way organizations prevent and diagnose disease in multi-billion dollar markets such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more.

Deep dive We explore the investor case for growth companies

Snapshot

Armed with promising study results and proven technology, LexaGene is getting ready to launch the LX2 Genetic Analyzer to underserved markets valued at an estimated US$40 billion